Exogenous estrogen and endogenous sex hormones

Medicine (United States)

Volumn 71, Issue 1, 1992, Pages 44-51

  Tazuke, Salli ^a   Khaw, Kay Tee ^a   Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRONE SULFATE; ETHINYLESTRADIOL; NORETHISTERONE ACETATE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; MENOPAUSE; NORMAL HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; STEROID BLOOD LEVEL;

AGED; AGING; ANALYSIS OF VARIANCE; BODY MASS INDEX; CALIFORNIA; COMPARATIVE STUDY; CROSS-SECTIONAL STUDIES; ESTROGENS, SYNTHETIC; HUMAN; MIDDLE AGE; SEX HORMONE-BINDING GLOBULIN; SEX HORMONES; SMOKING; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026541028     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/00005792-199201000-00004     Document Type: Article

References (60)

1. Abraham GE, Maroulis GB. Effect of exogenous estrogen on serum pregnenolone cortisol, and androgens in postmenopausal women. Obstet Gynecol 45: 271-74, 1975.
2. Anderson DC, Hopper BR, Lasley BL, Yen SSC. A simple method for the assay of eight steroids in small volumes of plasma. Steroids 28:179-96, 1976.
3. Anderson DC, Yen SSC. Effects of estrogens on adrenal 3 beta-hydroxysteroid dehydrogenase in ovariectomized women. J Clin Endocrinol Metab 43: 561-70, 1976.
4. Anderson DC. Sex hormone binding globulin. Clin Endocrinol 3: 69-96, 1974.
5. Barmach de Niepomniszsze AJ, Rosenfield RL, Hosseinian AH, Kim MH. Adrenal androgen production: Dependence on ACTH and gonadal function. Endocrinology 92: A-194, 1973.
6. Brien TG. Cortisol metabolism after oral contraceptives: total plasma cortisol and the free cortisol index. Br J Obstet Gynaecol 82: 987-91, 1975.
7. Burke CW. Biologically active cortisol in plasma of oestrogen-treated and normal subjects. Br Med J 2: 798-800, 1969.
8. Bush TL, Barrett-Connor E. Non-contraceptive estrogen use and cardiovascular disease. Epidemiologic Reviews 7: 80-104, 1985.
9. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 129:1120-31, 1989.
10. Cauley JA, Gutai JP, Sandler RB, LaPorte RE, Kuller LH, Sashin D. The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women. Am J Epidemiol 124: 752-61, 1986.
11. Criqui MH, Barrett-Connor E, Austin M. Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol 108: 367-72, 1978.
12. Cumming DC, Rebar RW, Hopper BR, Yen SSC. Evidence for an influence of the ovary on circulating dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 54: 1069, 1982.
13. DeCleyn K, Buytaert P, Coppens M. Carbohydrate metabolism during hormonal substitution therapy. Maturitas 11(3): 235-42, 1989.
14. Doe RP, Dickinson P, Zinneman HH, Seal US. Elevated nonproteinbound cortisol (NPC) in pregnancy, during estrogen administration and in carcinoma of the prostate. J Clin Endocrinol Metab 29: 757-66, 1969.
15. Doe RP, Zinneman HH, Flink EB, Ulstrom RD. Significance of the concentration of nonprotein-bound plasma cortisol in normal subjects, Cushing's syndrome, pregnancy and during estrogen therapy. J Clin Endocrinol Metab 20:1484-92, 1960.
16. Fahraeus L, Larsson-Cohn U. Oestrogens, gonadotrophins and sex hormone binding globulin during oral and cutaneous administration of oestradiol-17 beta to menopausal women. Acta Endocrinologia 101: 592-96, 1982.
17. Fern M, Rose DP, Fern EB. Effect of oral contraceptives on plasma androgenic steroids and their precursors. Obstet Gynecol 51: 541-44, 1978.
18. Fink B, Svenstrup B, Bennett P, Micic S, Moller S. Effect of oestrogen and progestagen on gonadotrophins and sex hormones in oophorectomized women. Eur J Obstet Gynecol Reprod Biol 27:145-52, 1988.
19. Genant HK, Baylink DJ, Gallagher JC. Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 161 (6, pt 2): 1842-46, 1989.
20. Geola FL, Frumar AM, Tataryn IV, Lu KH, Hershman JM, Eggena P, Sambhi MP, Judd HL. Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 51:620-25, 1980.
21. Gordon EM, Williams SR, Frenchek B, Mazur CA, Speroff L. Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII. J Lab Clin Med 111: 52-56, 1988.
22. Hazzard WR. Estrogen replacement and cardiovascular disease: serum lipids and blood pressure effects. Am J Obstet Gynecol 161 (6, pt 2): 1847-53, 1989.
23. Helgason S, Carlström K, Damber MG, Damber JE, Selstam G, Von Schoultz B. Effects of various oestrogens on circulating androgens and cortisol during replacement therapy in post-menopausal women. Maturitas 3: 301-8, 1981.
24. Heilman L, Yoshida K, Zumoff B, Levin J, Kream J, Fukushima D. The effect of medroxyprogesterone acetate on the pituitary-adrenal axis. J Clin Endocrinol Metab 42: 912-17, 1976.
25. Hopper BR, Yen SSC. Circulating concentrations of dehydroepiandrosteone and dehydroepiandrosterone sulfate during puberty. J Clin Endocrinol Metab 40:458-61, 1975.
26. Judd HL, Parker DC, Rakoff JS, Hopper BR, Yen SSC. Elucidation of mechanism(s) of the nocturnal rise of testosterone in men. J Clin Endocrine Metab 38:134-41, 1974.
27. Judd HL. Hormonal dynamics associated with the menopause. Clin Obstet Gynecol 19: 775-88, 1976.
28. Khaw KT, Tazuke S, Barrett-Connor E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 318: 1705-9, 1988.
29. Lee PA, Kowarski A, Migeon CJ, Blizzard RM. Lack of correlation between gonadotropin and adrenal androgen levels in agonadal children. J Clin Endocrinol Metab 40: 664-69, 1975.
30. Liu JH, Rasmussen DD, Rivier J, Vale W, Yen SSC. Pituitary responses to synthetic corticotropin-releasing hormone: absence of modulatory effects by estrogen and progestin. Am J Obstet Gynecol 157:1387-91, 1987.
31. Lobo R, Goebelsmann U, Brenner PF, Mishell DR, Jr. The effects of estrogen on adrenal androgens in oophorectomized women. Am J Obstet Gynecol 142: 471-78, 1982.
32. Lobo RA, Paul WI, Goebelsmann U. Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function. Obstet Gynecol 57: 69-73 1981
33. Lucky AW, Marynick SP, Rebar RW, Cutler GB, Glen M, Johnsonbaugh RE, Loriaux DL. Replacement oral ethinyloestradiol therapy for gonadal dysgenesis: growth and adrenal androgen secretion. Acta Endocrinologia 91: 519-28, 1979.
34. Madden JD, Milewich L, Parker CR Jr, Carr BR, Boyar RM, McDonald PC. The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate. Am J Obstet Gynecol 132: 380-84, 1978.
35. Mahajan DK, Billiar RB, Jassani M, Little AB. Ethinyl estradiol administration and plasma steroid concentrations in ovariectomized women. Am J Obstet Gynecol 130: 398, 1978.
36. Mandel FP, Geola FL, Lu JHK, Eggena P, Sambhi MP, Hershman JM, Judd HL. Biological effects of various doses of ethinyl estradiol in postmenopausal women. Obstet Gynecol 59: 673-79, 1982.
37. Meulenberg PMM, Ross HA, Swinkels LMJW, Benraad TJ. The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone. Clinica Chimica Acta 165: 379-85, 1987.
38. Nordin BE, Robertson A, Seamark RF, Bridges A, Philcox JC, Need AG, Horowitz M, Morris HA, Deam S. The relation between calcium absorption, serum dehydroepiandrosterone, and vertebral mineral density in postmenopausal women. J Clin Endocrinol Metab 60: 651, 1985.
39. Notelovitz M. Estrogen replacement therapy: indications, contraindications, and agent selection. Am J Obstet Gynecol 161 (6, pt 2): 1832-41, 1989.
40. Notelovitz M. Exercise, nutrition, and the coagulation effects of estrogen replacement on cardiovascular health. Obstet Gynecol Clin North Am 14:121-41, 1987.
41. Odell W, Parker LN. Control of adrenal androgen secretion. Endocrine Research 10: 617-30, 1984-85.
42. Parker LN. Control of adrenal androgen secretion. In: Adrenal Androgens in Clinical Medicine. San Diego, CA: Academic Press, pp. 30-57, 1989.
43. Peterson RE, Nokes GN, Chen PS, Black RL. Estrogens and adrenocortical function in man. J Clin Endocrinol Metab 20: 495-514, 1960.
44. Plager JE. The binding of androsterone sulfate, etiocholanolone sulfate and dehydroisoandrosterone sulfate by human plasma protein. J Clin Invest 44:1234-39, 1965.
45. Plager JE, Schmidt KG, Staubitz WJ. Increased unbound cortisol in the plasma of estrogen-treated subjects. J Clin Invest 43: 1066-72, 1964.
46. Rose DP, Fern M, Liskowski L, Milbrath JR. Effect of treatment with estrogen conjugates on endogenous plasma steroids. Obstet Gynecol 49: 80-82, 1977.
47. Rosenfield RL, Fang VS. The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teenagers. J Pediatr 85: 830-37, 1974.
48. Rosner W. A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity in human plasma. J Clin Endocrinol Metab 34: 983-88, 1972.
49. Sandberg AA, Slaunwhite WR. Transcortin: a corticosteroid-binding protein of plasma. II. Levels in various conditions and the effects of estrogens. J Clin Invest 38: 1290-97, 1959.
50. Sklar CA, Kaplan SL, Grumbach MM. Lack of effect of oestrogens on adrenal androgen secretion in children and adolescents with a comment on oestrogens and pubic hair growth. Clin Endocrinol 14: 311-20, 1981.
51. Sobrinho LG, Kase NG, Grunt JA. Changes in adrenocortisol function of patients with gonadal dysgenesis after treatment with estrogen. J Clin Endocrinol Metab 33: 110-14, 1971.
52. Taliaferro I, Cobey F, Leone L. Effect of diethylstilbestrol on plasma 17-hydroxy corticosteroid levels in humans. Proc Soc Exp Biol Med 92: 742-44, 1956.
53. Tremblay RR, Dube JY. Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 10: 599-605, 1974.
54. van Veelen H, Willemse P, Sleijfer D, Pratt J, Sluiter W, Doorenbos H. Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients. Cancer Chemo Pharm 12: 83-86, 1984.
55. van Veelen H, Willemse P, Sleijfer D, van der Ploeg E, Sluiter W, Doorenbos H. Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients. Cancer Chemo Pharm 15:167-70, 1985.
56. Veldhuis JD, Samojlik E, Evans WS, Rogol AD, Ridgeway CE, Crowley WF, Kolp L, Checinska E, Kirschner MA, Thomer MO, Stumpf P. Endocrine impact of pure estradiol replacement in postmenopausal women: Alterations in anterior pituitary hormone release and circulating sex steroid hormone concentrations. Am J Obstet Gynecol 155:334-39, 1986.
57. Vermeulen A. Androgen secretion after age 50 in both sexes. Hormone Res 18: 37-42, 1983.
58. Wame GL, Carter JN, Faiman C, Reyes FI, Winter JSD. Hormonal changes in girls with precocious adrenarche: a possible rule for estradiol or prolactin. J Pediatr 92: 743-47, 1978.
59. Yates J, Deshpande N. Kinetic studies on the enzymes catalysing the conversion of 17-α-hydroxyprogesteroneand dehydroepiandrosterone to androstenedione in the human adrenal gland in vitro. J Endocrinol 60: 27-35, 1974.
60. Zachmann M, Manella B, Eiholzer U, Bucher H, Prader A. Influence of oestrogen in high and low doses on plasma steroid concentrations in girls with tall stature and Turner syndrome. Acta Endocrinologia 106: 368-73, 1984.